SignatureFD’s Praxis Precision Medicines PRAX Stock Holding History

SignatureFD’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$11.9K	Buy	41 +20	+95%	+$6.62K	﹤0.01%	2651
2026 Q2	$7.03K	Sell	21 -9	-30%	-$2.85K	﹤0.01%	2767
2026 Q1	$9.7K	Buy	+30	New	+$9.28K	﹤0.01%	2527
2022 Q3	–	Sell	-14	Closed	-$1K	–	3290
2022 Q2	$1K	Sell	14 -6	-30%	-$640	﹤0.01%	2986
2022 Q1	$3K	Sell	20 -7	-26%	-$1.44K	﹤0.01%	2713
2021 Q4	$8K	Buy	27 +18	+200%	+$5.28K	﹤0.01%	2228
2021 Q3	$3K	Buy	+9	New	+$2.44K	﹤0.01%	2546

Other funds holding PRAX

Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

SEB Asset Management Stockholm $27B AUM

CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Moody Aldrich Partners Marblehead, Massachusetts $523M AUM 75.24% 1-Year Est. Return

Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return

Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return

Kornitzer Capital Management Shawnee Mission, Kansas $4.8B AUM 30.14% 1-Year Est. Return

SignatureFD's PRAX Position: Q3 2026 in Review

SignatureFD increased its Praxis Precision Medicines (PRAX) stake by 95% in Q3 2026, buying an estimated $6.62K and bringing the position to 41 shares worth $11.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2651.

SignatureFD first reported a position in PRAX in Q3 2021 and has held it in 7 quarters since. 87 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

SignatureFD held 41 shares of Praxis Precision Medicines worth $11.9K as of Q3 2026.
SignatureFD bought 20 Praxis Precision Medicines shares in Q3 2026, an estimated $6.62K.
Praxis Precision Medicines made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #2651 holding.
SignatureFD first reported a position in Praxis Precision Medicines in Q3 2021 and has held it in 7 quarters since.
87 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.